EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 23:16 ET (23-Jun-2026 03:16 GMT/UTC)

HIV antibody opens up new approaches for vaccine development and combination therapies

University of Cologne
Peer-Reviewed Publication

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by Professor Dr Florian Klein, opens up new perspectives for the development of vaccines and therapeutics against HIV-1 and was published in the journal „Nature Immunology“

Journal: Nature Immunology

Radiotherapy is more effective when administered at the right time of day

University of Seville
Peer-Reviewed Publication

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks. This study, which focused on the circadian protein Cryptochrome1 (CRY1), suggests that the time of day when radiotherapy is administered can significantly influence the effectiveness of treatment for certain types of cancer.

Journal: Nature Communications

Basic research on Listeria bacteria leads to unique cancer therapy

University of California - Berkeley
Peer-Reviewed Publication

Listeria bacteria generate a unique innate immune response that is being harnessed to boost the immune system in cancer patients. Scientists at UC Berkeley and a spinoff company eliminated the bacteria’s ability to cause disease while retaining its ability to rev up production of gamma delta T cells, which are associated with increased survival in cancer patients. They demonstrated the therapy’s safety in mice and seek approval to test it in pediatric leukemia patients.

Journal: mBio

Siemens Healthineers and Mayo Clinic expand strategic collaboration to enhance patient care through advanced technology

Mayo Clinic
Business Announcement

Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for people with those diseases and expand access to new imaging and interventional technologies.

Lung cancer drug offers a surprising new treatment against ovarian cancer

Mayo Clinic
Peer-Reviewed Publication

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.

Journal: Science Translational Medicine

Cancer Cell publication details development of cancer-induced cachexia and anorexia

University of Oklahoma
Peer-Reviewed Publication

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a “triangle regulation theory” of cancer-induced cachexia and anorexia.

Journal: Cancer Cell

Cancer researcher is awarded Sjöberg Prize for describing tumors’ evolution

Royal Swedish Academy of Sciences
Grant and Award Announcement

This year’s Sjöberg Prize of one million US dollars is awarded to a British cancer researcher who has provided fundamental knowledge about evolution in tumours. Charles Swanton, at the Francis Crick Institute in London, has described how tumours’ mutations arise and develop. His discoveries could help explain why treatments do not always work, as well as leading the way to more accurate diagnostics.

Mount Sinai study strengthens landmark evidence supporting lung-sparing surgery, offering hope for mesothelioma patients

The Mount Sinai Hospital / Mount Sinai School of Medicine
Peer-Reviewed Publication

A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected patients with pleural mesothelioma, a rare and aggressive cancer most often caused by asbestos exposure.

Journal: The Annals of Thoracic Surgery

Light-based sensor detects early molecular signs of cancer in the blood

Optica
Peer-Reviewed Publication

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

Journal: Optica

Identified aggressive prostate cancer with groundbreaking methods

Norwegian University of Science and Technology
Peer-Reviewed Publication

For the first time ever, researchers from the Norwegian University of Science and Technology (NTNU) have identified new characteristics of aggressive prostate cancer.

Journal: Nature Communications